TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center >
Dynamic Center
Dynamic Center
  • Review of key phase I studies of CHA in GBM and prospects for phase II/III clinical trials
        “2018 China BioMed Innovation and Investment Conference” was held in Suzhou International Conference Center on September 18,2018. Sichuan Jiuzhang Biological Science and Techno...
    [View details]
  • Thank-You Letter
    Sichuan Jiuzhang Biotech Co., Ltd. is a small private company in China.Jiuzhangcompany has been treated fairlyand guided by USPTO（US Patent and Trademark Office） and lawyer Allen Xuein the internation...
    [View details]
  • Cell Systems: Manipulating the IKZF1 gene is expected to enhance the efficacy of cancer immunotherapy
    Immunotherapies are some of the most promising emergent treatments for several cancers, yet there remains a majority of patients who do not benefit from them because their tumors in the body can escap...
    [View details]
  • Nature: Heavyweight results! Scientists have discovered that misregulation of key enzymes may induce leukemia and brain cancer
        Researchers from institutions such as the German Cancer Research Center have found that key enzymes responsible for breaking down specific amino acids in food may play animport...
    [View details]
    • Copyright 2017 Sichuan Jiuzhang Biological Science and Technology Co., Ltd
    Tel : 86-28-85121781 Address : No. 10，the Second South Keyuan Road, High-Tech District, Chengdu, Sichuan, China
    Shu ICP: 蜀ICP备09012251号-1 | Technology: 中联无限 http://www.cc01.com.cn